FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kazuyuki Yoshizaki

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Physiology

Anatomy

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Prabha Tiwari; Lokesh P Tripathi; Shandar Ahmad; Tomoyasu Isobe; Kenji Mizuguchi; Teppei Nishikawa-Matsumura; Soken-Nakazawa J Song; Kazuyuki Yoshizaki
Prediction and experimental validation of a putative non-consensus binding site for transcription factor STAT3 in serum amyloid A gene promoter.
Toru Hirano; Satoshi Hohki; Tadamitsu Kishimoto; Atsushi Kumanogoh; Michiko Narazaki; Atsushi Ogata; Nobuyuki Ohguro; Yoshihito Shima; Keisuke Hagihara; Kazuyuki Yoshizaki; Toshio Tanaka
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Kazuyuki Yoshizaki
Pathogenic role of IL-6 combined with TNF-α or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kazuyuki Yoshizaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Prabha Tiwari; Lokesh P Tripathi; Shandar Ahmad; Tomoyasu Isobe; Kenji Mizuguchi; Teppei Nishikawa-Matsumura; Soken-Nakazawa J Song; Kazuyuki Yoshizaki
Prediction and experimental validation of a putative non-consensus binding site for transcription factor STAT3 in serum amyloid A gene promoter.
Biochimica et biophysica acta 2013;1830(6):3650-5.
2012: Toru Hirano; Satoshi Hohki; Tadamitsu Kishimoto; Atsushi Kumanogoh; Michiko Narazaki; Atsushi Ogata; Nobuyuki Ohguro; Yoshihito Shima; Keisuke Hagihara; Kazuyuki Yoshizaki; Toshio Tanaka
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Modern rheumatology / the Japan Rheumatism Association 2012;22(2):298-302.
2011: Kazuyuki Yoshizaki
Pathogenic role of IL-6 combined with TNF-α or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases.
Advances in experimental medicine and biology 2011;691():141-50.
2010: Soken-Nakazawa J Song; Naohisa Tomosugi; Hiroshi Kawabata; Takayuki Ishikawa; Teppei Nishikawa; Kazuyuki Yoshizaki
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
Blood 2010;116(18):3627-34.
2009: Kazuyuki Yoshizaki
[New therapeutic strategy for autoimmune and chronic inflammatory disease based on clinical results using IL-6 blocking therapy with a humanized anti-IL-6 receptor antibody].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2009;129(6):667-74.
2008: Kazuyuki Yoshizaki
[Pathogenic analysis of chronic inflammatory disease based on the clinical results by IL-6 blocking therapy].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2008;31(2):104-12.
2008: Teppei Nishikawa; Keisuke Hagihara; Satoshi Serada; Tomoyasu Isobe; Atsumi Matsumura; Jian Song; Toshio Tanaka; Ichiro Kawase; Tetsuji Naka; Kazuyuki Yoshizaki
Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):3492-501.
2007: Toru Hirano; Keisuke Hagiharai; Mari Kawai; Yusuke Kuwahara; Tomoki Yamadori; Yoshihito Shima; Atsushi Ogata; Toshio Tanaka; Kazuyuki Yoshizaki; Ichiro Kawase
[Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2007;30(5):414-8.
2007: Makoto Nishida; Toshiki Moriyama; Kouki Ishii; Seiji Takashima; Kazuyuki Yoshizaki; Yoshiro Sugita; Keiko Yamauchi-Takihara
Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.
Clinica chimica acta; international journal of clinical chemistry 2007;384(1-2):99-104.
2005: Keisuke Hagihara; Teppei Nishikawa; Yasuhiro Sugamata; Jian Song; Tomoyasu Isobe; Tetsuya Taga; Kazuyuki Yoshizaki
Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression.
Genes to cells : devoted to molecular & cellular mechanisms 2005;10(11):1051-63.
2005: Norihiro Nishimoto; Yuzuru Kanakura; Katsuyuki Aozasa; Takeshi Johkoh; Minoru Nakamura; Shuji Nakano; Nobuaki Nakano; Yasuo Ikeda; Takeshi Sasaki; Kiyoshi Nishioka; Masamichi Hara; Hirokuni Taguchi; Yukihiko Kimura; Yoshiro Kato; Hideki Asaoku; Shunichi Kumagai; Fumio Kodama; Hideko Nakahara; Keisuke Hagihara; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.
Blood 2005;106(8):2627-32.
2005: Kanji Sugimoto; Norihiro Nishimoto; Tadamitsu Kishimoto; Kazuyuki Yoshizaki; Tsunehiko Nishimura
Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody.
Annals of nuclear medicine 2005;19(4):261-6.
2005: Yasuyuki Kai; Ichiro Takahashi; Hiromichi Ishikawa; Takachika Hiroi; Tsunekazu Mizushima; Chu Matsuda; Daisuke Kishi; Hiromasa Hamada; Hiroshi Tamagawa; Toshinori Ito; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Hikaru Matsuda; Hiroshi Kiyono
Colitis in mice lacking the common cytokine receptor gamma chain is mediated by IL-6-producing CD4+ T cells.
Gastroenterology 2005;128(4):922-34.
2005: Yoshihito Shima; Masayuki Iwano; Kazuyuki Yoshizaki; Toshio Tanaka; Ichiro Kawase; Norihiro Nishimoto
All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice.
Nephron. Experimental nephrology 2005;100(1):e54-62.
2004: Jian Song; Atsushi Yoshida; Yoshihiko Yamamoto; Harutaka Katano; Keisuke Hagihara; Shinichi Oka; Satoshi Kimura; Kazuyuki Yoshizaki
Viral load of human herpesvirus 8 (HHV-8) in the circulatory blood cells correlates with clinical progression in a patient with HHV-8-associated solid lymphoma with aids-associated Kaposi's sarcoma.
Leukemia & lymphoma 2004;45(11):2343-7.
2004: Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Jun Hashimoto; Junichi Azuma; Tadamitsu Kishimoto
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2004;50(6):1761-9.
2004: Masahiko Mihara; Masashi Shiina; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Ken-Ichi Akamatsu
Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
The Journal of rheumatology 2004;31(6):1132-8.
2004: Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; Akira Andoh; Takayuki Matsumoto; Takehira Yamamura; Junichi Azuma; Norihiro Nishimoto; Kazuyuki Yoshizaki; Takashi Shimoyama; Tadamitsu Kishimoto
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.
Gastroenterology 2004;126(4):989-96; discussion 947.
2004: Keisuke Hagihara; Teppei Nishikawa; Tomoyasu Isobe; Jian Song; Yasuhiro Sugamata; Kazuyuki Yoshizaki
IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system.
Biochemical and biophysical research communications 2004;314(2):363-9.
2003: Yukihiko Saeki; Toru Mima; Taeko Ishii; Atsushi Ogata; Hideyuki Kobayashi; Shiro Ohshima; Tetsushi Ishida; Youichiro Tabunoki; Hitoshi Kitayama; Masao Mizuki; Yoshinori Katada; Hideki Asaoku; Masayasu Kitano; Norihiro Nishimoto; Kazuyuki Yoshizaki; Masahiro Maeda; Shigeyuki Kon; Naokazu Kinoshita; Toshimitsu Uede; Ichiro Kawase
Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
British journal of haematology 2003;123(2):263-70.
2003: Norihiro Nishimoto; Kazuyuki Yoshizaki; Keiji Maeda; Taro Kuritani; Hitoshi Deguchi; Bunzo Sato; Nobuyuki Imai; Masaki Suemura; Takahiro Kakehi; Nobuhiro Takagi; Tadamitsu Kishimoto
Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
The Journal of rheumatology 2003;30(7):1426-35.
2003: Hideko Nakahara; Jian Song; Masamichi Sugimoto; Keisuke Hagihara; Tadamitsu Kishimoto; Kazuyuki Yoshizaki; Norihiro Nishimoto
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Arthritis and rheumatism 2003;48(6):1521-9.
2003: Sho Goya; Hiroto Matsuoka; Masahide Mori; Hiroshi Morishita; Hiroshi Kida; Yoichiro Kobashi; Terufumi Kato; Yoshio Taguchi; Tadashi Osaki; Isao Tachibana; Norihiro Nishimoto; Kazuyuki Yoshizaki; Ichiro Kawase; Seiji Hayashi
Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung.
The Journal of pathology 2003;200(1):82-7.
2002: Asao Katsume; Hiroyuki Saito; Yoshiki Yamada; Keigo Yorozu; Otoya Ueda; Ken-ichi Akamatsu; Norihiro Nishimoto; Tadamitsu Kishimoto; Kazuyuki Yoshizaki; Yoshiyuki Ohsugi
Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice.
Cytokine 2002;20(6):304-11.
2002: Makoto Okazaki; Yoshiki Yamada; Norihiro Nishimoto; Kazuyuki Yoshizaki; Masahiko Mihara
Characterization of anti-mouse interleukin-6 receptor antibody.
Immunology letters 2002;84(3):231-40.
2002: Masahiko Mihara; Norihiro Nishimoto; Kazuyuki Yoshizaki; Takashi Suzuki
Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.
Immunology letters 2002;84(3):223-9.
2002: Keisuke Hagihara; Norihiro Nishimoto; Kazuyuki Yoshizaki
[A humanized anti-IL-6 receptor antibody(MRA) in RA therapy].
Nihon rinsho. Japanese journal of clinical medicine 2002;60(12):2401-7.
2002: Jian Song; Takako Ohkura; Masamichi Sugimoto; Yasuko Mori; Reiko Inagi; Koichi Yamanishi; Kazuyuki Yoshizaki; Norihiro Nishimoto
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line.
Journal of medical virology 2002;68(3):404-11.
2002: Yoshihiko Kishima; Hiroyasu Yamamoto; Yoshitaka Izumoto; Kenya Yoshida; Hirayuki Enomoto; Mitsunari Yamamoto; Toshifumi Kuroda; Hiroaki Ito; Kazuyuki Yoshizaki; Hideji Nakamura
Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals.
The Journal of biological chemistry 2002;277(12):10315-22.
2001: Masahiko Mihara; M Kotoh; Norihiro Nishimoto; Y Oda; E Kumagai; N Takagi; K Tsunemi; Yoshiyuki Ohsugi; Tadamitsu Kishimoto; Kazuyuki Yoshizaki; Y Takeda
Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys.
Clinical immunology (Orlando, Fla.) 2001;98(3):319-26.
2000: Norihiro Nishimoto; T Okura; Jian Song; Reiko Inagi; Yasuko Mori; Koichi Yamanishi; Kazuyuki Yoshizaki
[Crosstalking between HIV and HHV-8 via IL-6 in AIDS].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2000;23(6):586-90.
2000: Norihiro Nishimoto; Tadamitsu Kishimoto; Kazuyuki Yoshizaki
Anti-interleukin 6 receptor antibody treatment in rheumatic disease.
Annals of the rheumatic diseases 2000;59 Suppl 1():i21-7.
2000: Katsuhiro Nishioka; Shiro Ohshima; Mitsuko Umeshita-Sasai; Norihiko Yamaguchi; Toru Mima; Shintaro Nomura; Norikazu Murata; M Shimizu; T Miyake; Kazuyuki Yoshizaki; Masaki Suemura; Tadamitsu Kishimoto; Yukihiko Saeki
Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPbeta and C/EBPdelta, in rheumatoid synovium.
Arthritis and rheumatism 2000;43(7):1591-6.
2000: Yasuko Mori; Norihiro Nishimoto; M Ohno; Reiko Inagi; Panadda Dhepakson; K Amou; Kazuyuki Yoshizaki; Koichi Yamanishi
Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion.
Journal of medical virology 2000;61(3):332-5.
2000: Masahiro Yamamoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Hiroaki Ito
IL-6 is required for the development of Th1 cell-mediated murine colitis.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4878-82.
2000: Masanobu Funamoto; Yasushi Fujio; Keita Kunisada; Shinji Negoro; Eiroh Tone; Tomoaki Osugi; Hisao Hirota; Masahiro Izumi; Kazuyuki Yoshizaki; K Walsh; Tadamitsu Kishimoto; Keiko Yamauchi-Takihara
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes.
The Journal of biological chemistry 2000;275(14):10561-6.
2000: Norihiro Nishimoto; A Ito; M Ono; H Tagoh; Takayuki Matsumoto; T Tomita; T Ochi; Kazuyuki Yoshizaki
IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.
International immunology 2000;12(2):187-93.
2000: Norihiro Nishimoto; M Sasai; Yoshihito Shima; Masashi Nakagawa; Takayuki Matsumoto; T Shirai; Tadamitsu Kishimoto; Kazuyuki Yoshizaki
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
Blood 2000;95(1):56-61.
1999: M Sasai; Yukihiko Saeki; Shiro Ohshima; Katsuhiro Nishioka; Toru Mima; Toshiyuki Tanaka; Yoshinori Katada; Kazuyuki Yoshizaki; Masaki Suemura; Tadamitsu Kishimoto
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.
Arthritis and rheumatism 1999;42(8):1635-43.
1999: K Deguchi; H Yagi; M Inada; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Toshihisa Komori
Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow.
Biochemical and biophysical research communications 1999;255(2):352-9.
1999: Norihiro Nishimoto; Tadamitsu Kishimoto; Kazuyuki Yoshizaki
Anticytokine therapy in autoimmune diseases.
Internal medicine (Tokyo, Japan) 1999;38(2):178-82.
1998: Takeshi Johkoh; Nestor L Müller; Kazuya Ichikado; Norihiro Nishimoto; Kazuyuki Yoshizaki; Osamu Honda; Noriyuki Tomiyama; H Naitoh; Hideji Nakamura; Shuji Yamamoto
Intrathoracic multicentric Castleman disease: CT findings in 12 patients.
Radiology 1998;209(2):477-81.
1998: Michiko Narazaki; Minoru Fujimoto; Takuya Matsumoto; Y Morita; Hiroshi Saito; T Kajita; Kazuyuki Yoshizaki; Tetsuji Naka; Tadamitsu Kishimoto
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(22):13130-4.
1998: Kazuyuki Yoshizaki; Norihiro Nishimoto; M Mihara; Tadamitsu Kishimoto
Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.
Springer seminars in immunopathology 1998;20(1-2):247-59.
1997: H Ogawa; H Ito; A Takeda; S Kanazawa; Masahiro Yamamoto; Hitomi Nakamura; Yoshinobu Kimura; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Universal skew of T cell receptor (TCR) V beta usage for Crohn's disease (CrD).
Biochemical and biophysical research communications 1997;240(3):545-51.
1997: Tetsuji Naka; Michiko Narazaki; M Hirata; Takuya Matsumoto; S Minamoto; A Aono; N Nishimoto; T Kajita; Tetsuya Taga; Kazuyuki Yoshizaki; S Akira; Tadamitsu Kishimoto
Structure and function of a new STAT-induced STAT inhibitor.
Nature 1997;387(6636):924-9.
1997: Norihiro Nishimoto; Yoshihito Shima; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Myeloma biology and therapy. Present status and future developments.
Hematology/oncology clinics of North America 1997;11(1):159-72.
1996: Shouji Hashimoto; Satoshi Tsukada; M Matsushita; Toshio Miyawaki; Yo Niida; Akihiro Yachie; S Kobayashi; T Iwata; H Hayakawa; H Matsuoka; I Tsuge; Tomoki Yamadori; T Kunikata; S Arai; Kazuyuki Yoshizaki; Naoyuki Taniguchi; Tadamitsu Kishimoto
Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Blood 1996;88(2):561-73.
1996: JT Tang; Hideya Yamazaki; Norihiro Nishimoto; T Inoue; Takayuki Nose; Masahiko Koizumi; Eiichi Tanaka; A Ogata; Kazuyuki Yoshizaki; T Inoue
Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma.
Anticancer research 1996;16(4A):2005-8.
1995: Hideya Yamazaki; Norihiro Nishimoto; H Oi; M Matsushita; A Ogata; Y Shima; T Inoue; JT Tang; Kazuyuki Yoshizaki; T Kishimoto
Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
Cytokine 1995;7(2):191-5.
1995: Y Shima; Norihiro Nishimoto; A Ogata; Y Fujii; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
Blood 1995;85(3):757-64.
1995: Y Tani; Norihiro Nishimoto; A Ogata; Y Shima; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Gp130 in human myeloma/plasmacytoma.
Current topics in microbiology and immunology 1995;194():229-33.
1994: A Ogata; Norihiro Nishimoto; Y Shima; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction.
Blood 1994;84(9):3040-6.
1994: Norihiro Nishimoto; A Ogata; Y Shima; Y Tani; H Ogawa; M Nakagawa; H Sugiyama; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
The Journal of experimental medicine 1994;179(4):1343-7.
1993: Hiroki Ohzato; Morito Monden; Kazuyuki Yoshizaki; A Ogata; Norihiro Nishimoto; M Gotoh; Tadamitsu Kishimoto; T Mori
Systemic production of interleukin-6 following acute inflammation.
Biochemical and biophysical research communications 1993;197(3):1556-62.
1993: T Kobayashi; K Hashimoto; K Matsumoto; Kazuyuki Yoshizaki; Kunihiko Yoshikawa
Analysis of the interleukin 6 receptor on normal human keratinocytes by digital imaging fluorescence microscopy.
The Journal of dermatology 1993;20(9):585-7.
1993: Hiroki Ohzato; Morito Monden; Kazuyuki Yoshizaki; M Gotoh; T Kanai; Koji Umeshita; T Tono; Norihiro Nishimoto; T Kishimoto; T Mori
Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys.
Surgery today 1993;23(6):521-7.
1992: Kazuyuki Yoshizaki; T Kuritani; Tadamitsu Kishimoto
Interleukin-6 in autoimmune disorders.
Seminars in immunology 1992;4(3):155-66.
1992: T Tono; Morito Monden; Kazuyuki Yoshizaki; L A Valdivia; Y Nakano; M Gotoh; Hiroki Ohzato; Yuichiro Doki; A Ogata; T Kishimoto
Biliary interleukin 6 levels as indicators of hepatic allograft rejection in rats.
Transplantation 1992;53(6):1195-201.
1992: A Ogata; H Tagoh; T Lee; T Kuritani; Y Takahara; T Shimamura; H Ikegami; M Kurimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto
A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA).
Journal of immunological methods 1992;148(1-2):15-22.
1992: Hiroki Ohzato; Kazuyuki Yoshizaki; Norihiro Nishimoto; A Ogata; H Tagoh; Morito Monden; M Gotoh; Tadamitsu Kishimoto; T Mori
Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery.
Surgery 1992;111(2):201-9.
1991: T Tono; Morito Monden; Kazuyuki Yoshizaki; L A Valdivia; Y Nakano; M Gotoh; Hiroki Ohzato; Yuichiro Doki; A Ogata; T Kishimoto
Interleukin 6 levels in bile following liver transplantation.
Transplantation proceedings 1991;23(1 Pt 1):630-1.
1990: Kazuyuki Yoshizaki; Norihiro Nishimoto; K Matsumoto; H Tagoh; Tetsuya Taga; Y Deguchi; T Kuritani; Toshio Hirano; K Hashimoto; N Okada
Interleukin 6 and expression of its receptor on epidermal keratinocytes.
Cytokine 1990;2(5):381-7.
1990: Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobutaka Eiraku; K Machigashira; H Tagoh; A Ogata; T Kuritani; Mitsuhiro Osame; Tadamitsu Kishimoto
Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Journal of the neurological sciences 1990;97(2-3):183-93.
1990: N Matsuzaki; F Saji; T Kameda; Kazuyuki Yoshizaki; T Okada; K Sawai; O Tanizawa
In vitro and in vivo production of interleukin-6 by fetal mononuclear cells.
Clinical immunology and immunopathology 1990;55(2):305-14.
1990: Kazuyuki Yoshizaki
[Clinical significance of cytokines-interleukin 6 in disease].
Rinsho byori. The Japanese journal of clinical pathology 1990;38(4):375-9.
1989: Kazuyuki Yoshizaki; Toshio Matsuda; Norihiro Nishimoto; T Kuritani; L Taeho; Katsuyuki Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.
Blood 1989;74(4):1360-7.
1989: Norihiro Nishimoto; Kazuyuki Yoshizaki; H Tagoh; Morito Monden; S Kishimoto; Toshio Hirano; Tadamitsu Kishimoto
Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.
Clinical immunology and immunopathology 1989;50(3):399-401.